ORIC P&L Curve

ORIC Pharmaceuticals, Inc. (ORIC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $814.7M, listed on NASDAQ, employing roughly 111 people, carrying a beta of 0.98 to the broader market. ORIC Pharmaceuticals, Inc. Led by Jacob Chacko, public since 2020-04-24.

A profit/loss curve charts the theoretical gain or loss of an options position across a range of underlying prices. It helps traders visualize risk, identify breakeven points, and compare strategies before committing capital.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Market Cap
$814.7M
Employees
111
IPO Date
2020-04-24
CEO
Jacob Chacko
Beta
0.98

As of Nov 13, 2026, the ORIC Pharmaceuticals, Inc. spot price is $7.92; P&L scenarios can be constructed from the options chain. Payoff diagrams should be rebuilt from the live options chain; the preceding values are illustrative and assume a single at-the-money straddle for reference.